I have read with great interest the paper by Yan Chao Lee et al. entitled "The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients"1. I would like here to provide arguments indicating that an alteration of the dopamine synthetic pathways is possibly involved in the pathophysiology of COVID-19. This article is protected by copyright. All rights reserved.